#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419373	Binding	Inhibition of C-terminal 6x-histidine tagged beta-catenin (138 to 686 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 /human BCL9 (350 to 375 residues) protein-protein interactions incubated for 1 hr by Alpha-screen assay	Homo sapiens	57	ALA4419168	assay format	Patent Bioactivity Data
2.	ALA4419374	Binding	Inhibition of C-terminal 6x-histidine tagged beta-catenin (138 to 686 residues) (unknown origin) expressed in Escherichia coli BL21 DE3/N-terminally biotinylated human E-cadherin (824 to 877 residues) protein-protein interactions by Alpha-screen assay	Homo sapiens	10	ALA4419168	assay format	Patent Bioactivity Data
3.	ALA4419375	Binding	Selectivity index, ratio of Ki for inhibition of C-terminal 6x-histidine tagged beta-catenin (138 to 686 residues) (unknown origin) expressed in Escherichia coli BL21 DE3/N-terminally biotinylated human E-cadherin (824 to 877 residues) protein-protein interactions by Alpha-screen assay to Ki for Inhibition of C-terminal 6x-histidine tagged beta-catenin (138 to 686 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 /human BCL9 (350 to 375 residues) protein-protein interactions incubated for 1 hr by Alpha-screen assay	Homo sapiens	10	ALA4419168	assay format	Patent Bioactivity Data
4.	ALA4419380	Binding	Inhibition of inhibited beta-catenin D145A mutant (unknown origin) expressed in Escherichia coli BL21 DE3 /human BCL9 (350 to 375 residues) protein-protein interactions by Alpha-screen assay	Homo sapiens	3	ALA4419168	assay format	Patent Bioactivity Data
5.	ALA4419381	Binding	Inhibition of inhibited beta-catenin E155A mutant (unknown origin) expressed in Escherichia coli BL21 DE3 /human BCL9 (350 to 375 residues) protein-protein interactions by Alpha-screen assay	Homo sapiens	3	ALA4419168	assay format	Patent Bioactivity Data
6.	ALA4419382	Binding	Inhibition of inhibited beta-catenin D145A/E155A mutant (unknown origin) expressed in Escherichia coli BL21 DE3 /human BCL9 (350 to 375 residues) protein-protein interactions by Alpha-screen assay	Homo sapiens	3	ALA4419168	assay format	Patent Bioactivity Data
7.	ALA4419401	Binding	Inhibition of beta-catenin/BCL9 (unknown origin) expressed in Wnt-activated HEK293 cells assessed as reduction in canonical Wnt signaling transactivation by Wnt-responsive luciferase reporter assay	Homo sapiens	2	ALA4419168	cell-based format	Patent Bioactivity Data
8.	ALA4419402	Binding	Inhibition of beta-catenin/BCL9 in Wnt-activated human SW480 cells assessed as reduction in canonical Wnt signaling transactivation by Wnt-responsive luciferase reporter assay	Homo sapiens	3	ALA4419168	cell-based format	Patent Bioactivity Data
9.	ALA4419403	Binding	Inhibition of beta-catenin/BCL9 in Wnt-activated human MDA-MB-231 cells assessed as reduction in canonical Wnt signaling transactivation by Wnt-responsive luciferase reporter assay	Homo sapiens	2	ALA4419168	cell-based format	Patent Bioactivity Data
10.	ALA4419416	Functional	Cytotoxicity in human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	3	ALA4419168	cell-based format	Patent Bioactivity Data
11.	ALA4419417	Functional	Cytotoxicity in human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	3	ALA4419168	cell-based format	Patent Bioactivity Data
12.	ALA4419419	Functional	Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	47	ALA4419168	cell-based format	Patent Bioactivity Data
13.	ALA4419420	Functional	Cytotoxicity in human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	2	ALA4419168	cell-based format	Patent Bioactivity Data
14.	ALA4419421	Functional	Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	2	ALA4419168	cell-based format	Patent Bioactivity Data
15.	ALA4419422	ADME	Cytotoxicity in human MCF10A cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	Homo sapiens	2	ALA4419168	cell-based format	Patent Bioactivity Data